Cefpodoxime marketing approved by FDA.
D000284:Administration, Oral; D001424:Bacterial Infections / Q000188:drug therapy; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D000097623:Cefpodoxime
D015296:Ceftizoxime; D000097623:Cefpodoxime